Search

Your search keyword '"Dellasala, Sara"' showing total 4 results
Start Over Author "Dellasala, Sara" Publisher elsevier bv
4 results on '"Dellasala, Sara"'

1. CML-217: Low-Dose Dasatinib 50 mg Daily Versus Standard-Dose Dasatinib 100 mg Daily in Newly Diagnosed Chronic Myeloid Leukemia: A Propensity Score Analysis

Author

Sasaki, Koji, primary, Jabbour, Elias, additional, Naqvi, Kiran, additional, Skinner, Jeffrey, additional, Anderson, Kristin, additional, Dellasala, Sara, additional, Yilmaz, Musa, additional, Ferrajoli, Alessandra, additional, Bose, Prithviraj, additional, Thompson, Philip, additional, Alvarado, Yesid, additional, Jain, Nitin, additional, Takahashi, Koichi, additional, Burger, Jan, additional, Estrov, Zeev, additional, Borthakur, Gautam, additional, Pemmaraju, Naveen, additional, Paul, Shilpa, additional, Pierce, Sherry, additional, Cortes, Jorge, additional, and Kantarjian, Hagop, additional

Published
2020
Full Text
View/download PDF

2. Pretreatment FMS like Tyrosine kinase-3 Internal Tandem duplication (FLT3-ITD) Mutant Allele Burden Does Not Predict Response to the Combination of Sorafenib and Azacytidine in Patients with Relapsed or High Risk Elderly Untreated Acute Myeloid Leukemia

Author

George, Binsah, primary, Cortes, Jorge, additional, Cabrero, Monica, additional, Jain, Nitin, additional, Konopleva, Marina, additional, Andreeff, Michael, additional, Tapan, Kadia, additional, Pierce, Sherry, additional, Dellasala, Sara, additional, Borthakur, Gautham, additional, Jabbour, Elias, additional, Garcia-Manero, Guillermo, additional, Kantarjian, Hagop, additional, and Ravandi, Farhad, additional

Published
2015
Full Text
View/download PDF

3. Long-term molecular and cytogenetic response and survival outcomes with imatinib 400 mg, imatinib 800 mg, dasatinib, and nilotinib in patients with chronic-phase chronic myeloid leukaemia: retrospective analysis of patient data from five clinical trials

Author

Jain, Preetesh, primary, Kantarjian, Hagop, additional, Alattar, Mona Lisa, additional, Jabbour, Elias, additional, Sasaki, Koji, additional, Gonzalez, Graciela Nogueras, additional, Dellasala, Sara, additional, Pierce, Sherry, additional, Verstovsek, Srdan, additional, Wierda, William, additional, Borthakur, Gautam, additional, Ravandi, Farhad, additional, O'Brien, Susan, additional, and Cortes, Jorge, additional

Published
2015
Full Text
View/download PDF

4. A Phase I/II Study of the Janus Kinase (JAK)1 and 2 Inhibitor Ruxolitinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Author

Pemmaraju, Naveen, primary, Kantarjian, Hagop, additional, Kadia, Tapan, additional, Cortes, Jorge, additional, Borthakur, Gautam, additional, Newberry, Kate, additional, Garcia-Manero, Guillermo, additional, Ravandi, Farhad, additional, Jabbour, Elias, additional, Dellasala, Sara, additional, Pierce, Sherry, additional, and Verstovsek, Srdan, additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results